Efficacy Result from a Phase 2, Double-Blind, Placebo-Controlled Study of CX-8998 a State-Dependent T-Type Calcium (Cav3) Channel Modulator in Essential Tremor Patients (T-CALM) (S4.008)
Year: 2019
Type: article
Source: Neurology
Authors: Spyros Papapetropoulos, Margaret Lee, Stacey Boyer, Andrew Krouse, Rajesh Pahwa, Kelly Lyons, William Ondo, H. Jinnah, Rodger Elble
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2977031859
